safety of glp-1 receptor agonists Pharmacological interventions for obesity in patients with inflammatory bowel disease: A systematic review agonist efficacy and Top GLP-1 Agonists Balance Weight
Description
A physician may need to evaluate persistent vomiting, severe abdominal pain, signs of dehydration, worsening reflux, gallbladder symptoms, low blood sugar risk in patients using diabetes medications, kidney function concerns, unintentional under-eating, rapid weakness or muscle loss, and medication interactions
doi: 10.1016/j.npep.2018.07.003 76 BrauerRWeiLMaTAthaudaDGirgesCVijiaratnamNet al
A new study found that females using GLP-1 drugs had about a 30% lower risk of developing breast cancer
Free Radic Biol Med
Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS
